Abu Dhabi: In a landmark achievement for the UAE, a pioneering health research initiative has launched into space aboard Axiom Mission 4 (Ax-4), which took off from NASA’s Kennedy Space Center in Florida on Wednesday after several postponements.
The mission marks a historic collaboration aimed at advancing medical possibilities for astronauts with insulin-dependent diabetes mellitus (IDDM)—a condition previously considered incompatible with spaceflight.
‘Suite Ride’ Project: A Space First for Diabetes Research
At the heart of this mission is the Suite Ride study, a groundbreaking collaboration between Burjeel Holdings, headquartered in Abu Dhabi, and Axiom Space. The initiative is set to evaluate the performance of Continuous Glucose Monitors (CGMs) and the stability of insulin in microgravity, potentially opening the door for individuals with diabetes to participate in future space missions.
“This research challenges the notion that a chronic condition like diabetes limits one’s potential. What better way to prove that wrong than in space—the final frontier,” said Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings.
Real-Time Health Monitoring in Orbit
Over a 14-day mission aboard the International Space Station (ISS), the four-member international crew will conduct more than 60 experiments from 31 countries, including studies in biology, physics, and human health.
The Suite Ride study will monitor CGMs in microgravity to validate their accuracy and reliability, using extensive preflight, inflight, and postflight protocols. Additionally, the study will assess insulin’s chemical stability and efficacy after space exposure, providing crucial insights into space medicine.
Dr. Mohammad Fityan, Chief Medical Officer at Burjeel Medical City and Clinical Lead of the research, said, “We are optimistic that our findings will contribute not only to space medicine but also to improving access to quality healthcare for underserved communities, particularly across the MENA region.”
Mission Crew and Wider Impact
Commanded by veteran NASA astronaut Peggy Whitson, the Ax-4 crew includes Shubhanshu Shukla (India), Sławosz Uznański-Wiśniewski (ESA/Poland), and Tibor Kapu (Hungary).
To engage the public, Burjeel Medical City is hosting an interactive exhibition highlighting the Suite Ride initiative and the UAE’s strides in space health. The UAE Embassy in Washington, D.C. also showcased the project as a pivotal achievement in the nation’s evolving space journey.
Global Relevance Amid Rising Diabetes Rates
With 783 million people projected to have diabetes by 2045, and an expected 87% increase in cases across the MENA region, the research holds global significance. The success of technologies tested in space could eventually support remote and resource-limited healthcare environments on Earth.
